OMDA: Omada Health, Inc. Market Capitalization-to-Revenue Ratio

Corporate company logo of Omada (OMDA)

Omada Health Inc (OMDA) creates a digital environment to combat chronic ailments by integrating software and sensors within the B2B segment. As a pioneer in digital therapeutics, management is proving the clinical utility of its products to insurers. The revenue multiple on the GURU.Markets chart, where the 2.70 level captures recent values, reflects market expectations. Business growth is based on deep partnerships with major healthcare operators.

OMDA Omada Health Inc P/S Multiple (06/07/2025 - 11/13/2026)

Omada Health Corp (OMDA) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
- market capitalization information:
General company analysis:omadahealth.com, OMDA
Product sample of Omada Health, Inc.

To minimize the risk of overpaying when selecting an entry point, it is necessary to assess the asset's market value relative to its actual sales. The P/S ratio, equal to 2.70, is calculated as the ratio of market capitalization to annual revenue, and an analysis of the industry-average P/S for Omada Health Inc (OMDA) allows for a comparison of the current valuation of Omada Health Inc (OMDA) with the stabilization phase in the digital health sector and the business's transition toward predictable cyclical growth.

Who Omada Health Inc competes with

VEEV (veeva.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple DOCS (Doximity)|Market Capitalization-to-Revenue Ratio HQY|Waystar Inc. - P/S Multiple|Price to Sales CorVel Corp.|PRVA: P/S Multiple|huronconsultinggroup.com (HURN) - P/S Multiple|Price-to-Revenue Ratio Certara|Price-to-Revenue Ratio OMCL|Market Cap to Revenue GDRX (GoodRx Corp)|Market Cap to Sales Volume SDGR|P/S Multiple PHR (Phreesia, Inc.)|Market Capitalization-to-Revenue Ratio EVH|HSTM: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio DH (Definitive Healthcare Corp)|CCSI: P/S Multiple|AGL - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Absci|Market Cap to Revenue Ratio SY (soyoung.com)|P/S Multiple NRC|Market Cap to Revenue Spok Holdings Inc SPOK|Price-to-Revenue Ratio OptimizeRx Corp. OPRX|TruBridge Corp (TBRG) - Price to Sales|SLP - Price-to-Revenue Ratio|SOPHiA GENETICS SA (SOPH) - Market Cap to Revenue|HCAT: P/S Multiple|Market Cap to Revenue Ratio CCLD|RSSS (Research Solutions, Inc.) - P/S Multiple|P/S Multiple DLH Holdings Corp|P/S Multiple ONMD|Price-to-Revenue Coefficient scienture.com|Healthcare Triangle, Inc. - Market Cap to Revenue|Market Cap to Sales Volume ISPC (iSpecimen Inc)|BFRG: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio WORX (SCWorx Inc)|MSP Recovery Inc (MSPR) - Price-to-Revenue Ratio|Market Cap to Revenue iCoreConnect|MEDS (TRxADE HEALTH) - P/S Multiple|Price to Sales Orgenesis Inc ORGS|P/S Multiple RCM|Sharecare Inc - Market Cap to Revenue Ratio|Price-to-Revenue Ratio Streamline Health Solutions STRM|syrahealth.com (SYRA) - Price to Sales|AMEH - Price-to-Revenue Ratio|Model N Inc (MODN) - Market Cap to Revenue|NXGN: P/S Multiple